<code id='BE8D0A8F01'></code><style id='BE8D0A8F01'></style>
    • <acronym id='BE8D0A8F01'></acronym>
      <center id='BE8D0A8F01'><center id='BE8D0A8F01'><tfoot id='BE8D0A8F01'></tfoot></center><abbr id='BE8D0A8F01'><dir id='BE8D0A8F01'><tfoot id='BE8D0A8F01'></tfoot><noframes id='BE8D0A8F01'>

    • <optgroup id='BE8D0A8F01'><strike id='BE8D0A8F01'><sup id='BE8D0A8F01'></sup></strike><code id='BE8D0A8F01'></code></optgroup>
        1. <b id='BE8D0A8F01'><label id='BE8D0A8F01'><select id='BE8D0A8F01'><dt id='BE8D0A8F01'><span id='BE8D0A8F01'></span></dt></select></label></b><u id='BE8D0A8F01'></u>
          <i id='BE8D0A8F01'><strike id='BE8D0A8F01'><tt id='BE8D0A8F01'><pre id='BE8D0A8F01'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:22
          Medical bill
          Adobe

          The cyberattack on Change Healthcare has fractured the country’s health care payment infrastructure. But it also exposed how complicated and vital these electronic pipes are.

          Using terms like “clearinghouse” and “electronic data interchange” are quick ways to lose an audience. But Ben Handel, a health economist at the University of California, Berkeley, for the past 13 years, has become intimately familiar with that language. When the Department of Justice sued to block UnitedHealth’s acquisition of Change Healthcare in 2022 — a case the agency ultimately lost — Handel was the government’s witness to explain what could happen to the payments and clearinghouse markets if the deal went through.

          advertisement

          He didn’t get into health economics to study the payment plumbing system, but understanding basic concepts about companies like Change Healthcare can illuminate the gravity of what is going on now. For example, the cyberattack and resulting outage isn’t just leading to a cash crunch for providers. It’s also creating uncertainty about how to handle basic requests to approve drugs and care and verify patients’ insurance.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          He's a Nobel laureate. Critics say he was misleading on Covid
          He's a Nobel laureate. Critics say he was misleading on Covid

          Photoillustration:AlexHogan/STAT;Sourcephoto:AFPviaGettyOnedaylastAugust,astheystruggledtofigureoutw

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Flagship, Pfizer team up in deal worth up to $7 billion

          PaulBiondiFlagshipPharmagiantPfizeristurningtoventurefirmFlagshipfornewdrugdevelopment,signingadealw